Tomoyuki Furuyashiki

Dr. Tomoyuki Furuyashiki

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Neuron
Verified
Journal Article
Closed access
XNXiang Nie
Xiang Nie
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
KTKohei Tanaka
Kohei Tanaka
ESEri Segi-Nishida
Eri Segi-Nishida
YIYuki Imoto
Yuki Imoto
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki

1 June 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TRTim Reid
Tim Reid
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
TIToshimasa Ishizaki
Toshimasa Ishizaki
GWGo Watanabe
Go Watanabe
NWNaoki Watanabe
Naoki Watanabe
SNShuh Narumiya
Shuh Narumiya
Using a mouse embryo cDNA library, we conducted a two-hybrid screening to identify new partners for the small GTPase Rho. One clone obtained by this procedure contained a novel cDNA of 291 base pairs and interacted strongly with RhoA and RhoC, weakly with RhoB, and not at all with Rac1 and Cdc42Hs. Full-length cDNAs were then isolated from a mouse brain library. While multiple splicing variants were common, we identified three cDNAs with an identical open reading frame encoding a 61-kDa protein that we named rhotekin (from the Japanese “teki,” meaning target). The N-terminal part of rhotekin, encoded by the initial cDNA and produced in bacteria as a glutathione S-transferase fusion protein, exhibited in vitro binding to 35S-labeled guanosine 5′-3-O-(thio)triphosphate-bound Rho, but not to Rac1 or Cdc42Hs in ligand overlay assays. In addition, this peptide inhibited both endogenous and GTPase-activating protein-stimulated Rho GTPase activity. The amino acid sequence of this region shares ~30% identity with the Rho-binding domains of rhophilin and a serine/threonine kinase, PKN, two other Rho target proteins that we recently identified (Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y., Kakizuka, A., and Narumiya, S. (1996) Science 271, 645-648). Thus, not only is rhotekin a novel partner for Rho, but it also belongs to a wide family of proteins that bear a consensus Rho-binding sequence at the N terminus. To our knowledge, this is the first conserved sequence for Rho effectors, and we have termed this region Rho effector motif class 1.

29 November 2000 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TIToshimasa Ishizaki
Toshimasa Ishizaki
YMYosuke Morishima
Yosuke Morishima
MOMuneo Okamoto
Muneo Okamoto
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
TKTakayuki Kato
Takayuki Kato
SNShuh Narumiya
Shuh Narumiya

1 May 2000 in Neuron
Verified
Journal Article
Closed access
HBHaruhiko Bito
Haruhiko Bito
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
HIHisamitsu Ishihara
Hisamitsu Ishihara
YSYoshikazu Shibasaki
Yoshikazu Shibasaki
KOKazumasa Ohashi
Kazumasa Ohashi
SNShuh Narumiya
Shuh Narumiya

20 May 2002 in Journal of Cell Biology
Verified
Journal Article
Open access
TTTakahiro Tsuji
Takahiro Tsuji
TIToshimasa Ishizaki
Toshimasa Ishizaki
MOMuneo Okamoto
Muneo Okamoto
CHChiharu Higashida
Chiharu Higashida
KKKazuhiro Kimura
Kazuhiro Kimura
SNShuh Narumiya
Shuh Narumiya
The small GTPase Rho acts on two effectors, ROCK and mDia1, and induces stress fibers and focal adhesions. However, how ROCK and mDia1 individually regulate signals and dynamics of these structures remains unknown. We stimulated serum-starved Swiss 3T3 fibroblasts with LPA and compared the effects of C3 exoenzyme, a Rho inhibitor, with those of Y-27632, a ROCK inhibitor. Y-27632 treatment suppressed LPA-induced formation of stress fibers and focal adhesions as did C3 exoenzyme but induced membrane ruffles and focal complexes, which were absent in the C3 exoenzyme-treated cells. This phenotype was suppressed by expression of N17Rac. Consistently, the amount of GTP-Rac increased significantly by Y-27632 in LPA-stimulated cells. Biochemically, Y-27632 suppressed tyrosine phosphorylation of paxillin and focal adhesion kinase and not that of Cas. Inhibition of Cas phosphorylation with PP1 or expression of a dominant negative Cas mutant inhibited Y-27632–induced membrane ruffle formation. Moreover, Crk-II mutants lacking in binding to either phosphorylated Cas or DOCK180 suppressed the Y-27632–induced membrane ruffle formation. Finally, expression of a dominant negative mDia1 mutant also inhibited the membrane ruffle formation by Y-27632. Thus, these results have revealed the Rho-dependent Rac activation signaling that is mediated by mDia1 through Cas phosphorylation and antagonized by the action of ROCK.

22 March 2011 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
TATomohiro Aoki
Tomohiro Aoki
MNM. Nishimura
M. Nishimura
TMT. Matsuoka
T. Matsuoka
KYK. Yamamoto
K. Yamamoto
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
SNS. Narumiya
S. Narumiya
BACKGROUND AND PURPOSE Cerebral aneurysm is a frequent cerebrovascular event and a major cause of fatal subarachnoid haemorrhage, but there is no medical treatment for this condition. Haemodynamic stress and, recently, chronic inflammation have been proposed as major causes of cerebral aneurysm. Nevertheless, links between haemodynamic stress and chronic inflammation remain ill‐defined, and to clarify such links, we evaluated the effects of prostaglandin E2 (PGE2), a mediator of inflammation, on the formation of cerebral aneurysms.EXPERIMENTAL APPROACH Expression of COX and prostaglandin E synthase (PGES) and PGE receptors were examined in human and rodent cerebral aneurysm. The incidence, size and inflammation of cerebral aneurysms were evaluated in rats treated with COX‐2 inhibitors and mice lacking each prostaglandin receptor. Effects of shear stress and PGE receptor signalling on expression of pro‐inflammatory molecules were studied in primary cultures of human endothelial cells (ECs).KEY RESULTS COX‐2, microsomal PGES‐1 and prostaglandin E receptor 2 (EP2) were induced in ECs in the walls of cerebral aneurysms. Shear stress applied to primary ECs induced COX‐2 and EP2. Inhibition or loss of COX‐2 or EP2in vivo attenuated each other's expression, suppressed nuclear factor κB (NF‐κB)‐mediated chronic inflammation and reduced incidence of cerebral aneurysm. EP2 stimulation in primary ECs induced NF‐κB activation and expression of the chemokine (C‐C motif) ligand 2, essential for cerebral aneurysm.CONCLUSIONS AND IMPLICATIONS These results suggest that shear stress activated PGE2‐EP2 pathway in ECs and amplified chronic inflammation via NF‐κB. We propose EP2 as a therapeutic target in cerebral aneurysm.